Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04929678 · ClinicalTrials.gov registry record · NA
Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis
A NA study, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04929678 is a NA study that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 10 participants.
The verdict
NCT04929678, a NA study, was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study was to establish probable benefits and evaluate the safety and preliminary effectiveness of the Braive™ GMS when used in the treatment of pediatric progressive scoliosis.
Interventions
- DEVICE Braive™ Growth Modulation System (Braive™ GMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2026-01-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04929678
The ClinicalTrials.gov registry entry for NCT04929678 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Braive™ Growth Modulation System (Braive™ GMS) is the first listed.
NCT04929678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04929678 about?
NCT04929678 is a clinical study titled "Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis". The purpose of this study was to establish probable benefits and evaluate the safety and preliminary effectiveness of the Braive™ GMS when used in the treatment of pediatric progressive scoliosis.
What is the current status of trial NCT04929678?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-12. Estimated completion is 2026-01-14.
What interventions are being tested in trial NCT04929678?
The interventions under investigation include: Braive™ Growth Modulation System (Braive™ GMS) (DEVICE).
Who is sponsoring clinical trial NCT04929678?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.